These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31751300)

  • 1. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
    Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
    Muir CA; Guttman-Jones M; Man EJ
    Endocrine; 2024 Jul; 85(1):370-379. PubMed ID: 38386168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone and other treatments for transgender males and non-binary trans masculine individuals.
    Dimakopoulou A; Seal LJ
    Best Pract Res Clin Endocrinol Metab; 2024 Sep; 38(5):101908. PubMed ID: 38997938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
    J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
    van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men.
    da Silva ED; Spritzer PM; Fighera TM
    J Endocrinol Invest; 2024 Aug; 47(8):2053-2060. PubMed ID: 38300501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen.
    Vlot MC; Wiepjes CM; de Jongh RT; T'Sjoen G; Heijboer AC; den Heijer M
    J Bone Miner Res; 2019 Oct; 34(10):1862-1872. PubMed ID: 31099910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing normality-persisting barriers: Current socio-demographic characteristics of 350 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Herrmann E; Bojunga J
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):241-246. PubMed ID: 31821578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
    Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
    Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic risk associated with gender-affirming hormone therapy.
    Mullins TLK; Mullins ES
    J Thromb Haemost; 2024 Aug; 22(8):2129-2139. PubMed ID: 38795871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.
    Scheres LJJ; Selier NLD; Nota NM; van Diemen JJK; Cannegieter SC; den Heijer M
    J Thromb Haemost; 2021 Apr; 19(4):1029-1037. PubMed ID: 33527671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
    Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
    J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-affirming hormone treatment modalities for transfemale & non-binary transfeminine individuals: A UK perspective.
    Sagar RC; Millson-Brown V
    Best Pract Res Clin Endocrinol Metab; 2024 Sep; 38(5):101921. PubMed ID: 39232976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
    Karalexi MA; Georgakis MK; Dimitriou NG; Vichos T; Katsimpris A; Petridou ET; Papadopoulos FC
    Psychoneuroendocrinology; 2020 Sep; 119():104721. PubMed ID: 32512250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.
    Nolan BJ; Cheung AS
    Intern Med J; 2024 Sep; 54(9):1450-1457. PubMed ID: 39056542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
    Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Testosterone Treatment Increase Anger Expression in a Population of Transgender Men?
    Motta G; Crespi C; Mineccia V; Brustio PR; Manieri C; Lanfranco F
    J Sex Med; 2018 Jan; 15(1):94-101. PubMed ID: 29175227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-Affirming Hormone Treatment Induces Facial Feminization in Transwomen and Masculinization in Transmen: Quantification by 3D Scanning and Patient-Reported Outcome Measures.
    Tebbens M; Nota NM; Liberton NPTJ; Meijer BA; Kreukels BPC; Forouzanfar T; Verdaasdonk RM; den Heijer M
    J Sex Med; 2019 May; 16(5):746-754. PubMed ID: 30926514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.